The global Montelukast Drug market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period.
Report Overview
Montelukast is a leukotriene receptor antagonist (LTRA) used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies.
This report provides a deep insight into the global Montelukast Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Montelukast Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Montelukast Drug market in any manner.
Global Montelukast Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- Merck & Co.
- Teva
- Mylan
- Glenmark Pharmaceuticals
- Hikma Group
- Sandoz
- Torrent Pharmaceuticals
- Lannett Company
- Apotex
- Dr. Reddys Laboratories
- Aurobindo Pharma
- Accord Healthcare
- Hetero
- Unimark
- Ajanta Pharma
- MACLEODS
- Jubilant Pharma
- Unichem Laboratories
- Amneal Pharmaceuticals
- Shanghai Anbison Lab
- Perrigo
- Cipla
- CSPC Ouyi Pharmaceutical
Market Segmentation (by Type)
Market Segmentation (by Application)
- Hospital
- Drug Store
- Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Montelukast Drug Market
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porters five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
Chapter Outline
Chapter 1 mainly introduces the statistical
scope of the report, market division standards, and market research methods.
Chapter 2 is an executive
summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Montelukast Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Montelukast Drug
1.2 Key Market Segments
1.2.1 Montelukast Drug Segment by Type
1.2.2 Montelukast Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Montelukast Drug Market Overview
2.1 Global Market Overview
2.1.1 Global Montelukast Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Montelukast Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Montelukast Drug Market Competitive Landscape
3.1 Global Montelukast Drug Sales by Manufacturers (2019-2024)
3.2 Global Montelukast Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Montelukast Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Montelukast Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Montelukast Drug Sales Sites, Area Served, Product Type
3.6 Montelukast Drug Market Competitive Situation and Trends
3.6.1 Montelukast Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Montelukast Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Montelukast Drug Industry Chain Analysis
4.1 Montelukast Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Montelukast Drug Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Montelukast Drug Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Montelukast Drug Sales Market Share by Type (2019-2024)
6.3 Global Montelukast Drug Market Size Market Share by Type (2019-2024)
6.4 Global Montelukast Drug Price by Type (2019-2024)
7 Montelukast Drug Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Montelukast Drug Market Sales by Application (2019-2024)
7.3 Global Montelukast Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Montelukast Drug Sales Growth Rate by Application (2019-2024)
8 Montelukast Drug Market Segmentation by Region
8.1 Global Montelukast Drug Sales by Region
8.1.1 Global Montelukast Drug Sales by Region
8.1.2 Global Montelukast Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Montelukast Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Montelukast Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Montelukast Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Montelukast Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Montelukast Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Merck and Co.
9.1.1 Merck and Co. Montelukast Drug Basic Information
9.1.2 Merck and Co. Montelukast Drug Product Overview
9.1.3 Merck and Co. Montelukast Drug Product Market Performance
9.1.4 Merck and Co. Business Overview
9.1.5 Merck and Co. Montelukast Drug SWOT Analysis
9.1.6 Merck and Co. Recent Developments
9.2 Teva
9.2.1 Teva Montelukast Drug Basic Information
9.2.2 Teva Montelukast Drug Product Overview
9.2.3 Teva Montelukast Drug Product Market Performance
9.2.4 Teva Business Overview
9.2.5 Teva Montelukast Drug SWOT Analysis
9.2.6 Teva Recent Developments
9.3 Mylan
9.3.1 Mylan Montelukast Drug Basic Information
9.3.2 Mylan Montelukast Drug Product Overview
9.3.3 Mylan Montelukast Drug Product Market Performance
9.3.4 Mylan Montelukast Drug SWOT Analysis
9.3.5 Mylan Business Overview
9.3.6 Mylan Recent Developments
9.4 Glenmark Pharmaceuticals
9.4.1 Glenmark Pharmaceuticals Montelukast Drug Basic Information
9.4.2 Glenmark Pharmaceuticals Montelukast Drug Product Overview
9.4.3 Glenmark Pharmaceuticals Montelukast Drug Product Market Performance
9.4.4 Glenmark Pharmaceuticals Business Overview
9.4.5 Glenmark Pharmaceuticals Recent Developments
9.5 Hikma Group
9.5.1 Hikma Group Montelukast Drug Basic Information
9.5.2 Hikma Group Montelukast Drug Product Overview
9.5.3 Hikma Group Montelukast Drug Product Market Performance
9.5.4 Hikma Group Business Overview
9.5.5 Hikma Group Recent Developments
9.6 Sandoz
9.6.1 Sandoz Montelukast Drug Basic Information
9.6.2 Sandoz Montelukast Drug Product Overview
9.6.3 Sandoz Montelukast Drug Product Market Performance
9.6.4 Sandoz Business Overview
9.6.5 Sandoz Recent Developments
9.7 Torrent Pharmaceuticals
9.7.1 Torrent Pharmaceuticals Montelukast Drug Basic Information
9.7.2 Torrent Pharmaceuticals Montelukast Drug Product Overview
9.7.3 Torrent Pharmaceuticals Montelukast Drug Product Market Performance
9.7.4 Torrent Pharmaceuticals Business Overview
9.7.5 Torrent Pharmaceuticals Recent Developments
9.8 Lannett Company
9.8.1 Lannett Company Montelukast Drug Basic Information
9.8.2 Lannett Company Montelukast Drug Product Overview
9.8.3 Lannett Company Montelukast Drug Product Market Performance
9.8.4 Lannett Company Business Overview
9.8.5 Lannett Company Recent Developments
9.9 Apotex
9.9.1 Apotex Montelukast Drug Basic Information
9.9.2 Apotex Montelukast Drug Product Overview
9.9.3 Apotex Montelukast Drug Product Market Performance
9.9.4 Apotex Business Overview
9.9.5 Apotex Recent Developments
9.10 Dr. Reddys Laboratories
9.10.1 Dr. Reddys Laboratories Montelukast Drug Basic Information
9.10.2 Dr. Reddys Laboratories Montelukast Drug Product Overview
9.10.3 Dr. Reddys Laboratories Montelukast Drug Product Market Performance
9.10.4 Dr. Reddys Laboratories Business Overview
9.10.5 Dr. Reddys Laboratories Recent Developments
9.11 Aurobindo Pharma
9.11.1 Aurobindo Pharma Montelukast Drug Basic Information
9.11.2 Aurobindo Pharma Montelukast Drug Product Overview
9.11.3 Aurobindo Pharma Montelukast Drug Product Market Performance
9.11.4 Aurobindo Pharma Business Overview
9.11.5 Aurobindo Pharma Recent Developments
9.12 Accord Healthcare
9.12.1 Accord Healthcare Montelukast Drug Basic Information
9.12.2 Accord Healthcare Montelukast Drug Product Overview
9.12.3 Accord Healthcare Montelukast Drug Product Market Performance
9.12.4 Accord Healthcare Business Overview
9.12.5 Accord Healthcare Recent Developments
9.13 Hetero
9.13.1 Hetero Montelukast Drug Basic Information
9.13.2 Hetero Montelukast Drug Product Overview
9.13.3 Hetero Montelukast Drug Product Market Performance
9.13.4 Hetero Business Overview
9.13.5 Hetero Recent Developments
9.14 Unimark
9.14.1 Unimark Montelukast Drug Basic Information
9.14.2 Unimark Montelukast Drug Product Overview
9.14.3 Unimark Montelukast Drug Product Market Performance
9.14.4 Unimark Business Overview
9.14.5 Unimark Recent Developments
9.15 Ajanta Pharma
9.15.1 Ajanta Pharma Montelukast Drug Basic Information
9.15.2 Ajanta Pharma Montelukast Drug Product Overview
9.15.3 Ajanta Pharma Montelukast Drug Product Market Performance
9.15.4 Ajanta Pharma Business Overview
9.15.5 Ajanta Pharma Recent Developments
9.16 MACLEODS
9.16.1 MACLEODS Montelukast Drug Basic Information
9.16.2 MACLEODS Montelukast Drug Product Overview
9.16.3 MACLEODS Montelukast Drug Product Market Performance
9.16.4 MACLEODS Business Overview
9.16.5 MACLEODS Recent Developments
9.17 Jubilant Pharma
9.17.1 Jubilant Pharma Montelukast Drug Basic Information
9.17.2 Jubilant Pharma Montelukast Drug Product Overview
9.17.3 Jubilant Pharma Montelukast Drug Product Market Performance
9.17.4 Jubilant Pharma Business Overview
9.17.5 Jubilant Pharma Recent Developments
9.18 Unichem Laboratories
9.18.1 Unichem Laboratories Montelukast Drug Basic Information
9.18.2 Unichem Laboratories Montelukast Drug Product Overview
9.18.3 Unichem Laboratories Montelukast Drug Product Market Performance
9.18.4 Unichem Laboratories Business Overview
9.18.5 Unichem Laboratories Recent Developments
9.19 Amneal Pharmaceuticals
9.19.1 Amneal Pharmaceuticals Montelukast Drug Basic Information
9.19.2 Amneal Pharmaceuticals Montelukast Drug Product Overview
9.19.3 Amneal Pharmaceuticals Montelukast Drug Product Market Performance
9.19.4 Amneal Pharmaceuticals Business Overview
9.19.5 Amneal Pharmaceuticals Recent Developments
9.20 Shanghai Anbison Lab
9.20.1 Shanghai Anbison Lab Montelukast Drug Basic Information
9.20.2 Shanghai Anbison Lab Montelukast Drug Product Overview
9.20.3 Shanghai Anbison Lab Montelukast Drug Product Market Performance
9.20.4 Shanghai Anbison Lab Business Overview
9.20.5 Shanghai Anbison Lab Recent Developments
9.21 Perrigo
9.21.1 Perrigo Montelukast Drug Basic Information
9.21.2 Perrigo Montelukast Drug Product Overview
9.21.3 Perrigo Montelukast Drug Product Market Performance
9.21.4 Perrigo Business Overview
9.21.5 Perrigo Recent Developments
9.22 Cipla
9.22.1 Cipla Montelukast Drug Basic Information
9.22.2 Cipla Montelukast Drug Product Overview
9.22.3 Cipla Montelukast Drug Product Market Performance
9.22.4 Cipla Business Overview
9.22.5 Cipla Recent Developments
9.23 CSPC Ouyi Pharmaceutical
9.23.1 CSPC Ouyi Pharmaceutical Montelukast Drug Basic Information
9.23.2 CSPC Ouyi Pharmaceutical Montelukast Drug Product Overview
9.23.3 CSPC Ouyi Pharmaceutical Montelukast Drug Product Market Performance
9.23.4 CSPC Ouyi Pharmaceutical Business Overview
9.23.5 CSPC Ouyi Pharmaceutical Recent Developments
10 Montelukast Drug Market Forecast by Region
10.1 Global Montelukast Drug Market Size Forecast
10.2 Global Montelukast Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Montelukast Drug Market Size Forecast by Country
10.2.3 Asia Pacific Montelukast Drug Market Size Forecast by Region
10.2.4 South America Montelukast Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Montelukast Drug by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Montelukast Drug Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Montelukast Drug by Type (2025-2030)
11.1.2 Global Montelukast Drug Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Montelukast Drug by Type (2025-2030)
11.2 Global Montelukast Drug Market Forecast by Application (2025-2030)
11.2.1 Global Montelukast Drug Sales (Kilotons) Forecast by Application
11.2.2 Global Montelukast Drug Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Montelukast Drug Market Size Comparison by Region (M USD)
Table 5. Global Montelukast Drug Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Montelukast Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Montelukast Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Montelukast Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Montelukast Drug as of 2022)
Table 10. Global Market Montelukast Drug Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Montelukast Drug Sales Sites and Area Served
Table 12. Manufacturers Montelukast Drug Product Type
Table 13. Global Montelukast Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Montelukast Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Montelukast Drug Market Challenges
Table 22. Global Montelukast Drug Sales by Type (Kilotons)
Table 23. Global Montelukast Drug Market Size by Type (M USD)
Table 24. Global Montelukast Drug Sales (Kilotons) by Type (2019-2024)
Table 25. Global Montelukast Drug Sales Market Share by Type (2019-2024)
Table 26. Global Montelukast Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global Montelukast Drug Market Size Share by Type (2019-2024)
Table 28. Global Montelukast Drug Price (USD/Ton) by Type (2019-2024)
Table 29. Global Montelukast Drug Sales (Kilotons) by Application
Table 30. Global Montelukast Drug Market Size by Application
Table 31. Global Montelukast Drug Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Montelukast Drug Sales Market Share by Application (2019-2024)
Table 33. Global Montelukast Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global Montelukast Drug Market Share by Application (2019-2024)
Table 35. Global Montelukast Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global Montelukast Drug Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Montelukast Drug Sales Market Share by Region (2019-2024)
Table 38. North America Montelukast Drug Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Montelukast Drug Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Montelukast Drug Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Montelukast Drug Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Montelukast Drug Sales by Region (2019-2024) & (Kilotons)
Table 43. Merck and Co. Montelukast Drug Basic Information
Table 44. Merck and Co. Montelukast Drug Product Overview
Table 45. Merck and Co. Montelukast Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Merck and Co. Business Overview
Table 47. Merck and Co. Montelukast Drug SWOT Analysis
Table 48. Merck and Co. Recent Developments
Table 49. Teva Montelukast Drug Basic Information
Table 50. Teva Montelukast Drug Product Overview
Table 51. Teva Montelukast Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Teva Business Overview
Table 53. Teva Montelukast Drug SWOT Analysis
Table 54. Teva Recent Developments
Table 55. Mylan Montelukast Drug Basic Information
Table 56. Mylan Montelukast Drug Product Overview
Table 57. Mylan Montelukast Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Mylan Montelukast Drug SWOT Analysis
Table 59. Mylan Business Overview
Table 60. Mylan Recent Developments
Table 61. Glenmark Pharmaceuticals Montelukast Drug Basic Information
Table 62. Glenmark Pharmaceuticals Montelukast Drug Product Overview
Table 63. Glenmark Pharmaceuticals Montelukast Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Glenmark Pharmaceuticals Business Overview
Table 65. Glenmark Pharmaceuticals Recent Developments
Table 66. Hikma Group Montelukast Drug Basic Information
Table 67. Hikma Group Montelukast Drug Product Overview
Table 68. Hikma Group Montelukast Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Hikma Group Business Overview
Table 70. Hikma Group Recent Developments
Table 71. Sandoz Montelukast Drug Basic Information
Table 72. Sandoz Montelukast Drug Product Overview
Table 73. Sandoz Montelukast Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Sandoz Business Overview
Table 75. Sandoz Recent Developments
Table 76. Torrent Pharmaceuticals Montelukast Drug Basic Information
Table 77. Torrent Pharmaceuticals Montelukast Drug Product Overview
Table 78. Torrent Pharmaceuticals Montelukast Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Torrent Pharmaceuticals Business Overview
Table 80. Torrent Pharmaceuticals Recent Developments
Table 81. Lannett Company Montelukast Drug Basic Information
Table 82. Lannett Company Montelukast Drug Product Overview
Table 83. Lannett Company Montelukast Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Lannett Company Business Overview
Table 85. Lannett Company Recent Developments
Table 86. Apotex Montelukast Drug Basic Information
Table 87. Apotex Montelukast Drug Product Overview
Table 88. Apotex Montelukast Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Apotex Business Overview
Table 90. Apotex Recent Developments
Table 91. Dr. Reddys Laboratories Montelukast Drug Basic Information
Table 92. Dr. Reddys Laboratories Montelukast Drug Product Overview
Table 93. Dr. Reddys Laboratories Montelukast Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Dr. Reddys Laboratories Business Overview
Table 95. Dr. Reddys Laboratories Recent Developments
Table 96. Aurobindo Pharma Montelukast Drug Basic Information
Table 97. Aurobindo Pharma Montelukast Drug Product Overview
Table 98. Aurobindo Pharma Montelukast Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Aurobindo Pharma Business Overview
Table 100. Aurobindo Pharma Recent Developments
Table 101. Accord Healthcare Montelukast Drug Basic Information
Table 102. Accord Healthcare Montelukast Drug Product Overview
Table 103. Accord Healthcare Montelukast Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Accord Healthcare Business Overview
Table 105. Accord Healthcare Recent Developments
Table 106. Hetero Montelukast Drug Basic Information
Table 107. Hetero Montelukast Drug Product Overview
Table 108. Hetero Montelukast Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Hetero Business Overview
Table 110. Hetero Recent Developments
Table 111. Unimark Montelukast Drug Basic Information
Table 112. Unimark Montelukast Drug Product Overview
Table 113. Unimark Montelukast Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Unimark Business Overview
Table 115. Unimark Recent Developments
Table 116. Ajanta Pharma Montelukast Drug Basic Information
Table 117. Ajanta Pharma Montelukast Drug Product Overview
Table 118. Ajanta Pharma Montelukast Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Ajanta Pharma Business Overview
Table 120. Ajanta Pharma Recent Developments
Table 121. MACLEODS Montelukast Drug Basic Information
Table 122. MACLEODS Montelukast Drug Product Overview
Table 123. MACLEODS Montelukast Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. MACLEODS Business Overview
Table 125. MACLEODS Recent Developments
Table 126. Jubilant Pharma Montelukast Drug Basic Information
Table 127. Jubilant Pharma Montelukast Drug Product Overview
Table 128. Jubilant Pharma Montelukast Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Jubilant Pharma Business Overview
Table 130. Jubilant Pharma Recent Developments
Table 131. Unichem Laboratories Montelukast Drug Basic Information
Table 132. Unichem Laboratories Montelukast Drug Product Overview
Table 133. Unichem Laboratories Montelukast Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. Unichem Laboratories Business Overview
Table 135. Unichem Laboratories Recent Developments
Table 136. Amneal Pharmaceuticals Montelukast Drug Basic Information
Table 137. Amneal Pharmaceuticals Montelukast Drug Product Overview
Table 138. Amneal Pharmaceuticals Montelukast Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 139. Amneal Pharmaceuticals Business Overview
Table 140. Amneal Pharmaceuticals Recent Developments
Table 141. Shanghai Anbison Lab Montelukast Drug Basic Information
Table 142. Shanghai Anbison Lab Montelukast Drug Product Overview
Table 143. Shanghai Anbison Lab Montelukast Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 144. Shanghai Anbison Lab Business Overview
Table 145. Shanghai Anbison Lab Recent Developments
Table 146. Perrigo Montelukast Drug Basic Information
Table 147. Perrigo Montelukast Drug Product Overview
Table 148. Perrigo Montelukast Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 149. Perrigo Business Overview
Table 150. Perrigo Recent Developments
Table 151. Cipla Montelukast Drug Basic Information
Table 152. Cipla Montelukast Drug Product Overview
Table 153. Cipla Montelukast Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 154. Cipla Business Overview
Table 155. Cipla Recent Developments
Table 156. CSPC Ouyi Pharmaceutical Montelukast Drug Basic Information
Table 157. CSPC Ouyi Pharmaceutical Montelukast Drug Product Overview
Table 158. CSPC Ouyi Pharmaceutical Montelukast Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 159. CSPC Ouyi Pharmaceutical Business Overview
Table 160. CSPC Ouyi Pharmaceutical Recent Developments
Table 161. Global Montelukast Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 162. Global Montelukast Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 163. North America Montelukast Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 164. North America Montelukast Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 165. Europe Montelukast Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 166. Europe Montelukast Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 167. Asia Pacific Montelukast Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 168. Asia Pacific Montelukast Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 169. South America Montelukast Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 170. South America Montelukast Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 171. Middle East and Africa Montelukast Drug Consumption Forecast by Country (2025-2030) & (Units)
Table 172. Middle East and Africa Montelukast Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 173. Global Montelukast Drug Sales Forecast by Type (2025-2030) & (Kilotons)
Table 174. Global Montelukast Drug Market Size Forecast by Type (2025-2030) & (M USD)
Table 175. Global Montelukast Drug Price Forecast by Type (2025-2030) & (USD/Ton)
Table 176. Global Montelukast Drug Sales (Kilotons) Forecast by Application (2025-2030)
Table 177. Global Montelukast Drug Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Montelukast Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Montelukast Drug Market Size (M USD), 2019-2030
Figure 5. Global Montelukast Drug Market Size (M USD) (2019-2030)
Figure 6. Global Montelukast Drug Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Montelukast Drug Market Size by Country (M USD)
Figure 11. Montelukast Drug Sales Share by Manufacturers in 2023
Figure 12. Global Montelukast Drug Revenue Share by Manufacturers in 2023
Figure 13. Montelukast Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Montelukast Drug Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Montelukast Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Montelukast Drug Market Share by Type
Figure 18. Sales Market Share of Montelukast Drug by Type (2019-2024)
Figure 19. Sales Market Share of Montelukast Drug by Type in 2023
Figure 20. Market Size Share of Montelukast Drug by Type (2019-2024)
Figure 21. Market Size Market Share of Montelukast Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Montelukast Drug Market Share by Application
Figure 24. Global Montelukast Drug Sales Market Share by Application (2019-2024)
Figure 25. Global Montelukast Drug Sales Market Share by Application in 2023
Figure 26. Global Montelukast Drug Market Share by Application (2019-2024)
Figure 27. Global Montelukast Drug Market Share by Application in 2023
Figure 28. Global Montelukast Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global Montelukast Drug Sales Market Share by Region (2019-2024)
Figure 30. North America Montelukast Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Montelukast Drug Sales Market Share by Country in 2023
Figure 32. U.S. Montelukast Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Montelukast Drug Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Montelukast Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Montelukast Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Montelukast Drug Sales Market Share by Country in 2023
Figure 37. Germany Montelukast Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Montelukast Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Montelukast Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Montelukast Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Montelukast Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Montelukast Drug Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Montelukast Drug Sales Market Share by Region in 2023
Figure 44. China Montelukast Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Montelukast Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Montelukast Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Montelukast Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Montelukast Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Montelukast Drug Sales and Growth Rate (Kilotons)
Figure 50. South America Montelukast Drug Sales Market Share by Country in 2023
Figure 51. Brazil Montelukast Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Montelukast Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Montelukast Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Montelukast Drug Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Montelukast Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Montelukast Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Montelukast Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Montelukast Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Montelukast Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Montelukast Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Montelukast Drug Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Montelukast Drug Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Montelukast Drug Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Montelukast Drug Market Share Forecast by Type (2025-2030)
Figure 65. Global Montelukast Drug Sales Forecast by Application (2025-2030)
Figure 66. Global Montelukast Drug Market Share Forecast by Application (2025-2030)
